Work

FADS3 fuels ccRCC progression via lipid-droplet/TGF-β receptors axis bridging metabolic reprogramming and epithelial plasticity

Year: 2025

Type: article

Abstract: BACKGROUND: The abnormal accumulation of lipid droplets in clear cell renal cell carcinoma (ccRCC) is related to metabolic reprogramming. However, the mechanism between metabolic reprogramming and tumor progression in ccRCC remains to be explored. METHODS: Utilize multiple omics technologies to predict the relationship between fatty acid metabolism and tumor progression, and identify the key regulatory proteins and mechanisms. The role of proteins in influencing tumor progression and fatty acid metabolism was explored from both in vivo and in vitro. The mechanism of the regulatory protein was analyzed and verified by co-immunoprecipitation and mass spectrometry. RESULTS: Multimodal analysis revealed that fatty acid desaturase 3 (FADS3), as a key molecule connecting fatty acid metabolism and Epithelial-mesenchymal transition (EMT), was upregulated in clinical samples of ccRCC and participated in the immune regulation, and was positively correlated with clinical stage and poor prognosis. Functionally, FADS3 promoted cell proliferation and EMT in vivo and in vitro as well as sunitinib resistance, and induced fatty acid synthesis and lipid droplet storage. Mechanistically, FADS3 activates the phosphorylation of Smad2/3 through autocrine Transforming Growth Factor-β (TGF-β). The lipid droplets induced by FADS3 could act as a reservoir of acetyl-CoA, promoting the acetylation of Smad2 and inducing the upregulation of TGF-β receptors, thereby promoting the proliferation and EMT. CONCLUSION: Our study confirmed FADS3 as a key intermediate protein regulating fatty acid metabolism and tumor progression, which was expected to be a potential diagnostic and prognostic biomarker for ccRCC.

Source: International Journal of Surgery

DOI: 10.1097/js9.0000000000004094